Dr MacArthur is Professor of Medicine in the Division of Infectious Diseases at the Medical College of Georgia at Augusta University. His current research interests include HIV, sepsis, HCV, and viral respiratory pathogens.
Post-Test on Hepatitis C in Primary Care
Take this brief quiz to see what you’ve learned about the challenges and opportunities of HCV management.
Hepatitis C Drugs Meet Resistance Issues
Resistance-associated variants limit the activity of some drugs, but HIV infection treatment may offer some guidance.
Hepatitis C: What If You Do Not Treat?
Severe outcomes may ensue in a high percentage of patients. The authors discuss the consequences in this brief podcast.
Newer Hepatitis C Drugs Mean Direct Action
The “modern era” of treatment features multiple DAAs that target specific steps within the HCV life cycle.
Medicaid Is Tight on Hepatitis C Drug Coverage
State Medicaid programs and private insurance companies have balked at providing these drugs to their insured customers. But the tide is turning.
Hepatitis C Report: What Tests to Order
Testing is recommended for the persons who are more likely to have the virus but not know it.
Hepatitis C Screening for High Risk Patients
Patients can be identified at earlier stages of disease, before serious liver damage develops, and have improved clinical outcomes.
Hepatitis C Report: Tuning in to a Silent Epidemic
Knowing the origin and causes could help clinicians better determine who to screen and treat.
SPECIAL REPORT: Hepatitis C and Primary Care
Primary care physicians can play an expanding role in achieving the benefits of testing, care, and treatment to help stem the epidemic.
HIV Infection in the Elderly
There is general consensus among public health authorities that the elderly are not being screened for HIV as frequently as are younger persons. But there is compelling reason to do so.
By clicking Accept, you agree to become a member of the UBM Medica Community.